SELLAS Life Sciences Group, Inc. (SLS)

4.245 -0.26 (-5.88%) USD  |  NASDAQ  |  Jan 23, 16:00
4.28 +0.04 (+0.82%) After-Hours: 16:45
More

SELLAS Life Sciences Group Price Target Num Estimates

Price Target Num Estimates Chart

View Price Target Num Estimates for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Num Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Num Estimates Range, Past 5 Years

View Price Target Num Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Num Estimates Benchmarks

View Price Target Num Estimates Benchmarks
Start Trial
GT Biopharma, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Geron Corp. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade